Articles & Events

World Vaccine Congress Europe

Meet Pratia at ESMO 2026

Meet Pratia at SCRS US in Orlando

The Humaneva Insights Podcast: Listen to Episode 1

ASCO 2026: Turn Oncology Data into Smarter Trial Strategy

Reduce Delays from Operational Gaps in Oncology Clinical Trials

Pratia expands into Türkiye through Atlas acquisition

Pratia, part of Humaneva Group, today announced the majority investment into Atlas, one of Türkiye’s leading providers of services supporting clinical trials across the country. This investment marks the entry of Pratia into the Turkish market.

Leadership transition at Pratia to support global growth

Pratia is pleased to announce a strategic leadership evolution that supports the company’s continued global expansion and further strengthens its integrated clinical research operations.

Pratia accelerates U.S. expansion with majority investment in P1 Trials

Pratia LLC, part of Humaneva Group, today announced the acquisition of a majority stake in P1 Trials, a U.S.-based early phase oncology clinical research network.